A prognostic model for SARS-CoV-2 breakthrough infection: Analyzing a prospective cellular immunity cohort.
Yang M, Meng Y, Hao W, Zhang J, Liu J, Wu L, Lin B, Liu Y, Zhang Y, Yu X, Wang X, Gong Y, Ge L, Fan Y, Xie C, Xu Y, Chang Q, Zhang Y, Qin X.
Yang M, et al.
Int Immunopharmacol. 2024 Apr 20;131:111829. doi: 10.1016/j.intimp.2024.111829. Epub 2024 Mar 14.
Int Immunopharmacol. 2024.
PMID: 38489974